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A B S T R A C T
The aim of the study was to determine prevalence of the signs and symptoms related to esophageal dysfunction in irri-
table bowel syndrome (IBS) patients, and to investigate sensorimotor function impairment based on the esophageal ma-
nometry study, thus to determine the correlation between them. The study included 30 patients with IBS, 14 of them with
diarrhea (IBSd) and 16 with constipation (IBSc) as a predominant discomfort. Control group consisted of 30 healthy
subjects. The patients were included in the study on the basis of the Rome criteria for IBS. In addition to thorough his-
tory and physical examination patient underwent esophagogastroduodenoscopy and esophageal manometry. The values
of esophageal manometry obtained in healthy subjects served as controls in manometry studies. The patients with IBS
suffered a great number of both colonic and extracolonic signs and symptoms, however, there was no statistically signifi-
cant difference in the prevalence of particular symptoms between the two patient subgroups. In comparison with healthy
subjects, the patients suffering from IBS showed pathologically altered values in the majority of parameters of esopha-
geal motility. Comparison of the two subgroups of IBS patients according to esophageal motility characteristics yielded
differences in only few of them. The results obtained in the study could explain why the patients with IBS quite com-
monly complain of the symptoms related to upper gastrointestinal tract, such as heartburn and chest pain of noncardiac
genesis. The results also suggest that the IBS might be associated with considerably more extensive smooth muscle or
innervation changes than presumed before.
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Introduction
Irritable bowel syndrome (IBS) is a functional disor-
der of the gastrointestinal system characterized by ab-
dominal pain related to bowel emptying, defecation im-
pairment, and abdominal distention1. In 1988, the Rome
criteria for functional gastrointestinal disorders were
presented by an expert group at the XIII International
Congress of Gastroenterology2. In 2006 expert group pre-
sented Rome III criteria which are the current standard.
According to these criteria, the diagnosis of IBS is made
on the basis of characteristic signs and symptoms of the
disease, i.e. 'positive diagnosis’ rather than by elimina-
tion of other diseases. These criteria define IBS as a
pathologic entity with three different clinical forms: syn-
drome subgroup predominated by diarrhea, subgroup
predominated by constipation, and subgroup with ab-
dominal distension and/or abdominal pain3 (Table 1).
IBS is one of the most common and at the same time
least known diseases in gastroentrology4–9. The preva-
lence of IBS in West European countries and USA has
been estimated to range between 5% and 25%, and is
more common in female population2–5. In a large epi-
demiologic study conducted in the American population,
9.4% of subjects met the Rome criteria for IBS1,6,9–11. Un-
fortunately, complete epidemiologic data on IBS in Cro-
atia have been lacking to date. There was only one study
carried out in 2002 in 500 subjects recruited from the
Zagreb population, which found the prevalence of IBS to
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be 28%. The figure is relatively high in comparison with
the results reported elsewhere, however, the author at-
tributes it to the impact of war and postwar stressors8.
The pathogenesis of IBS remains unknown. These pa-
tients are considered to suffer from disturbances in the
bowel sensorimotor function, central nervous system
(CNS) impairments, psychologic disturbances, and ef-
fects of stress; in addition, the role of certain intestinal
(luminal) factors has also been suggested. Anyhow, there
is no specific, unique pathophysiologic disorder to differ-
entiate the disease from organic diseases of the gastroin-
testinal system1,2,10.
IBS patients frequently also have symptoms that are
not characteristic of the distal part of the gastrointesti-
nal system. The upper gastrointestinal system symptoms
such as heartburn, early satiety, nausea and vomiting oc-
cur in 25% to 50%, and intermittent dyspepsia (pain or
discomfort localized in the upper abdomen) in as many as
90% of patients12. Dyspepsia is so common in IBS that
some authors consider it a component of the IBS clinical
picture. One third of patients with dyspepsia are free
from defecation problems, whereas others exhibit similar
motility impairments and hypersensitivity of the small
and large intestine and upper gastrointestinal system13.
There are relatively many studies dealing with small
and large intestine motility impairments. Although clini-
cal observations on the high prevalence of the upper gas-
trointestinal tract symptoms in IBS patients are beyond
any doubt, reliable studies and definite data on the rate
of esophageal motility impairments in these patients are
still lacking.
The aim of the present study was to assess the preva-
lence of the signs and symptoms related to esophageal
dysfunction in IBS patients, and to investigate the eso-
phageal sensorimotor function impairment based on the
esophageal manometry findings, thus to determine the




Thirty IBS patients (19 female and 11 male) aged
>18, suffering from upper gastrointestinal tract discom-
forts, and 30 healthy age-matched subjects (18 female
and 12 male) were included in the study (Table 2). IBS
patients were included on the basis of Rome criteria and
exclusion of a potential organic gastrointestinal disease.
Therefore, normal findings of the following tests were re-
quired for patient entry in the study: complete blood
count, erythrocyte sedimentation rate, basic biochemis-
try parameters (potassium, sodium, blood glucose, urea,
creatinine, hepatic transaminases, serum amylases), ne-
gative stool bacteriology and parasitology, negative blood
in stool, and normal upper abdomen ultrasonography.
IBS patients were divided into two subgroups: IBSd –
IBS predominated by diarrhea (10 women and 6 men),
and IBSc – IBS predominated by constipation (9 women
and 6 men, Table 3).
Methods
Besides thorough history and physical examination,
the following diagnostic methods were performed: eso-
phagogastroduodenoscopy14 and esophageal manometry
with 6-channel catheter15.
Esophageal manometry was performed by computed
manometry (Albyn Medical, Griffon) in fasting state and
after 48-hour medicamentous therapy interruption. The
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TABLE 1
ROME III CRITERIA FOR THE DIAGNOSIS OF IRRITABLE BOWEL SYNDROME
1. For at least 12 weeks, which need not be consecutive, of the preceding 12 months, the patient must have abdominal discom-
fort or pain associated with at least 2 of the folowing 3 features
a. Pain relieved by defecation
b. Onset associated with change in stool frequency
c. Onset associated with change in stool form
2. Positive two or more of the following items on at least ¼ episodes or days:
a. Changes in stool frequency (more than 3 per day or less than 3 per week);
b. Changes in stool consistency (pelleted/hard or loose/liquid);
c. Changes in stool passage (straining, urgency, incomplete evacuation);
d. Mucous stool; and/or
e. Abdominal distension
TABLE 2
GENERAL CHARACTERISTICS OF STUDY GROUP
IBS (n=30) Control (n=30) p
Age (yrs) 46.9 ± 10.21 46.2 ± 9.45 ns
Sex
Male 11 (36.6%) 12 (40.0%) ns
Female 19 (63.4%) 18 (60.0%) ns
Education
Elementary 9 (30.0%) 11 (36.6%) ns
Secondary 15 (50.0%) 14 (46.7%) ns
idctlparUniversity 6 (20.0%) 5 (16.6%) ns
BMI 27.37 ± 3.15 28.33 ± 4.9 ns
IBS – irritable bowel syndrome, BMI – body mass index
measurements were done by use of a 6-channel catheter
with distal openings distributed at variable distance, 5
cm apart (3 openings) or radially distributed at the same
level (3 openings). Each of the catheter lumina was
perfused with distilled water flowing at a rate of 1.36
ml/min. Pressure converters were connected to the free
ends of the catheter for computer recording of pressure
curves. The tip of the catheter, previously introduced
through the nose to the stomach was slowly pulled out
through the esophagus while continuously recording pre-
ssure values at rest in various projections. The lower
esophageal sphincter pressure was measured by station-
ary and rapid pull-through technique. The catheter was
left for 5 min in place in the lower esophageal region to
record the number of spontaneous contractions not in-
duced by deglutition and expressed as number of con-
tractions per minute. The occurrence of simultaneous
contractions and incomplete propagation contractions
was also recorded. Then the catheter was so placed as to
cover the complete body of the esophagus with its open-
ings, the most distal opening placed 5 cm above the upper
edge of the lower esophageal sphincter. Contraction wa-
ves after 10 gulps of 5 ml water each were determined.
The upper esophageal sphincter pressure was recorded
by use of the stationary method of catheter withdrawal.
The dynamics of all esophageal pressures was recorded
and stored in a computer, allowing for subsequent analy-
sis of the data obtained1,16. The esophageal manometry
parameters are: position, length, resting pressure, ability
of relaxation upon deglutition of upper and lower esopha-
geal sphincter; contractions (normal, repetitive, absent),
mean peristaltic peak pressure for upper, medial and
lower esophagus, peristaltic activity (coordinated, simul-
taneous, incomplete propagation) and mean rate of peri-
staltic wave.
Statistics
A number of statistical methods were employed in the
study. The methods of descriptive statistics were regu-
larly used for all variables according to defined groups,
and included arithmetic mean, standard deviation, mini-
mal and maximal values, and Kolmogorov test of distri-
bution normality. Depending on the characteristics of the
data obtained, the methods of parametric or nonpara-
metric statistics were used to determine the significance
of between-group differences (t-test, analysis of variance,
correlation test, c2-test, Pearson’s c2-test with Yates cor-
rection in 2 ´ 2 tables). The Statistica Version 10 soft-
ware was used in statistical analysis.
Results
There was no statistically significant difference be-
tween the group of IBS patients and control group of
healthy subjects according to age, sex, level of education
and body mass index. There was a female predominance
in both IBS and control group (M/F ratio: 63%/37% and
60%/40%, respectively, Table 2). The two IBS subgroups
did not differ significantly according to age, sex and level
of education, however, they did differ according to body
mass index in favour of the IBSd subgroup (Table 3).
Considering the upper gastrointestinal tract symp-
toms occurring in IBS patients, dyspepsia present in 87%
of study patients showed highest prevalence, followed by
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TABLE 4
PREVALENCE OF UPPER GASTROINTESTINAL TRACT SIGNS AND SYMPTOMS IN IBS PATIENTS
IBS (n= 30) IBSd (n=16) IBSc (n=14) p
Epigastric pain 14 (47%) 7 (44%) 7 (50%) ns
Pain posteriorly to sternum 6 (20%) 4 (25%) 2 (14%) ns
Heartburn 21 (70%) 12 (75%) 9 (64%) ns
Regurgitation 12 (40%) 7 (44%) 5 (36%) ns
Dysphagia 3 (10%) 2 (13%) 1 (10%) ns
Eructation 21 (70%) 11 (69%) 10 (71%) ns
Vomiting 5 (17%) 3 (19%) 2 (14%) ns
Globus sensation 23 (77%) 12 (75%) 11 79%) ns
Dyspepsia 26 (87%) 13 (81%) 13 (93%) ns
IBSd – irritable bowel syndrome with predominant diarrhea, IBSc – irritable bowel syndrome with predominant constipation, BMI –
body mass index
TABLE 3
GENERAL CHARACTERISTICS OF IBS SUBGROUPS
IBSd (n=16) IBSc (n=14) p
Age (yrs) 47.3 ± 10.25 46.4 ± 10.15 ns
Sex
Male 6 (37.5%) 5 (35.7%) ns
Female 10 (62.5%) 9 (64.3%) ns
Education
Elementary 5 (31.3%) 4 (28.6%) ns
Secondary 6 (37.5%) 7 (50.0%) ns
University 5 (31.3%) 3 (21.4%) ns
BMI 28.7 ± 3.8 26.5 ± 4.3 <0.05
IBSd – irritable bowel syndrome with predominant diarrhea,
IBSc – irritable bowel syndrome with predominant constipation,
BMI – body mass index
globus sensation, heartburn and frequent belching. Dys-
phagia was the most infrequent symptom, present in
10% of study patients. There was no statistically signifi-
cant difference between the two IBS subgroups in the
prevalence of any of the symptoms determined (Table 4).
Endoscopic examination of the upper segment of the
alimentary tract revealed normal findings in 57% of IBS
patients. Reflux esophagitis according to Savary-Miller
was endoscopically verified in 43% of IBS patients, none
of them with the disease stage III or IV. There was no sta-
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TABLE 5
ENDOSCOPICALLY VERIFIED LESIONS OF ESOPHAGUS, STOMACH AND DUODENUM IN IBS PATIENTS
IBS IBSd IBSc p
Normal finging 17 (57%) 8 (50%) 9 (64%) ns
Reflux esophagitis* 13 (43%) 5 (31%) 8 (57%) ns
Grade 1 10 (33%) 4 (25%) 6 (43%) ns
Grade 2 3 (10%) 1 (6%) 2 (14%) ns
Grade 3 0 (0%) 0 (0%) 0 (0%) ns
Grade 4 0 (0%) 0 (0%) 0 (0%) ns
Antral gastritis 11 (37%) 6 (38%) 5 (36%) ns
Duodenitis 9 (30%) 5 (31%) 4 (29%) ns
H. pylori positive 7 (23%) 3 (19%) 4 (29%) ns
IBS – irritable bowel syndrome, IBSd – irritable bowel syndrome with predominant diarrhea, IBSc – irritable bowel syndrome with
predominant constipation, BMI – body mass index; *Savary-Miller classification
TABLE 6
MANOMETRY CHARACTERISTICS OF IBS PATIENTS AND NORMAL CONTROL SUBJECTS
IBS (n= 30) Control (n=30) p
Lower esophageal sphincter
Total length (mm) 35 ± 5 38 ± 7 ns
abdominal segment 15 ± 6 28 ± 6 p<0.05
thoracic segment 20 ± 8 10 ± 5 p<0.01
Resting pressure (mmHg) 11 ± 8 17 ± 7 p<0.01
abdominal segment 12 ± 8 18 ± 8 p<0.01
thoracic segment 10 ± 4 15 ± 6 p<0.01
Relaxation upon deglutition (mmHg) 2 ± 1 0 ± 2 ns
Body of esophagus
Contraction (n=30)
normal 123 (41%) 270 (90%) p<0.01
repetitive 132 (44%) 30 (10%) p<0.01
absent 45 (15%) 0 (0%) p<0.01
Mean contraction duration (s) 3 ± 0.5 3.3 ± 0.4 ns
Mean peristaltic peak pressure (mmHg)
upper esophagus 78 ± 12 74 ± 9 p<0.05
medial esophagus 95 ± 15 91 ± 13 p<0.05
lower esophagus 78 ± 11 76 ± 10 ns
Peristaltic activity (n=300)
coordinated 210 (70%) 300 (100%) p<0.01
simultaneous 45 (15%) 0 (0%) p<0.01
incomplete propagation 45 (15%) 0 (0%) p<0.01
Mean rate of peristaltic wave (cm/s) 5.2 ± 1.05 4.6 ± 0.9 ns
Upper esophageal sphincter
Length (mm) 28 ± 10 30 ± 12 ns
Resting pressure (mmHg) 135 ± 16 129 ± 15 p<0.05
Relaxation upon deglutition (mmHg) –3.9 ± 1.5 –3.5 ± 1.5 ns
IBS – irritable bowel syndrome
tistically significant difference between the two IBS sub-
groups in the prevalence of any of these endoscopic find-
ings. Helicobacter (H.) pylori was isolated from gastric
mucosa in seven (23%) IBS patients (Table 5).
Results of the manometric studies of the lower esoph-
ageal sphincter obtained in the groups of IBS patients
and healthy controls showed decreased resting pressure
in the group of IBS patients. While total sphincter length
showed no statistical difference between IBS patients
and control group, lengths of thoracic and abdominal
part were significantly different (Table 6). Analysis of
two IBS subgroups revealed higher resting pressure of
lower esophageal sphincter in the IBSc subgroup (Table
7). There was no statistically significant difference either
between the IBS and control group or between the two
IBS subgroups in the mean value of the lower esophageal
sphincter relaxation to deglutition (Tables 6 and 7). As-
sessment of the esophageal body manometric character-
istics revealed IBS patients to have statistically signifi-
cant difference for all estimated manometric parameters
besides mean rate of peristaltic wave. A completely nor-
mal motor activity was only present in 41% of the patient
population versus 90% of the control group. The most
pronounced changes included frequent repetitive con-
traction waves, elevated amplitude of contraction waves
in the proximal two-thirds of the esophagus and in-
creased prevalence of simultaneous peristaltic activity
(Table 6). Some of this changes in motility parameters of
esophageal body were more common in IBSd subgroup
(Table 7). Considering the upper gastrointestinal sphin-
cter motility, there was no significant between-group dif-
ference in the sphincter length, whereas resting pressure
was higher in the group of IBS patients (Table 6). These
changes were also more pronounced in the IBSd sub-
group (Table 7).
Discussion
Based on the clinical experience indicating a great
number of extracolic symptoms occurring in IBS pa-
tients, and postulating the existence of more or less gen-
eralized intestinal dysfunction, we embarked upon the
present study to determine the prevalence of symptoms
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TABLE 7
MANOMETRY CHARACTERISTICS OF ESOPHAGUS IN IBS PATIENTS ACCORDING TO IBS SUBGROUPS
IBSd (n= 16) IBSc (n=14) p
Lower esophageal sphincter
Total length (mm) 34 ± 5 36 ± 6 ns
abdominal segment 14 ± 5 16 ± 7 ns
thoracic segment 20 ± 8 20 ± 8 ns
Resting pressure (mmHg) 9 ± 7 13 ± 9 <0.05
abdominal segment 11 ± 8 15 ± 8 ns
thoracic segment 7 ± 4 11 ± 5 ns
Relaxation upon deglutition (mmHg) 2 ± 1 2 ± 1 ns
Body of esophagus
Contraction (n=30)
normal 48 (30%) 49 (35%) ns
repetitive 84 (53%) 65 (47%) ns
absent 28 (18%) 25 (18%) ns
Mean contraction duration (s) 3.2±0.5 2.8 ± 0.5 ns
Mean peristaltic peak pressure (mmHg)
upper esophagus 80 ± 13 76 ± 11 <0.05
medial esophagus 98 ± 14 95 ± 13 ns
lower esophagus 75 ± 11 80 ± 11 <0.05
Peristaltic activity (n=300)
coordinated 88 (55%) 119 (85%) <0.01
simultaneous 32 (20%) 14 (10%) <0.05
incomplete propagation 40 (25%) 21 (15%) <0.05
Mean rate of peristaltic wave (cm/s) 5.3 ± 1 5.1 ± 1.1 ns
Upper esophageal sphincter
Length (mm) 30 ± 11 25 ± 9 ns
Resting pressure (mmHg) 147 ± 35 123 ± 38 <0.05
Relaxation upon deglutition (mmHg) –1 ± 1.5 –1 ± 1.5 ns
IBSd – irritable bowel syndrome with predominant diarrhea, IBSc – irritable bowel syndrome with predominant constipation
associated with esophageal dysfunction, and to objectify
them by use of endoscopy and esophageal manometry.
The study included two subgroups of IBS patients:
those with IBS and diarrhea, and those with IBS and
constipation as the predominant symptom of the disease.
We embarked upon the study of the manometric and clin-
ical features of these two IBS forms on the basis of litera-
ture reports identifying them as the two IBS extremes,
which should thus be expected to differ significantly ac-
cording to the motility parameter values1,5,7. It should be
emphasized that the two subgroups of IBS patients dif-
fered according to body mass index, which was higher in
IBS patients with diarrhea as the predominant symp-
tom. This is consistent with literature data, attributing it
to the higher ‘susceptibility’ to stress due to obesity in
these patients9.
In the present study, discomforts in the upper gastro-
intestinal tract were reported by the majority, i.e. more
than two-thirds of study patients. These recurrent dis-
comforts pose great burden upon the patients and usu-
ally cause extensive diagnostic procedure in IBS patients.
The high prevalence of the symptomatology otherwise
primarily associated with esophageal and duodenal dis-
eases in IBS patients points to generalized impairment of
the gastrointestinal system motility9,12,16.
According to Smart et al. study, the prevalence of re-
flux disease in IBS patients ranges between 22% and
48%17. Prevalence of reflux esophagitis in our IBS pa-
tients was 43%, mostly grade 1 and 2. 23% of IBS pa-
tients had positive test for H. pylori. It should be noted
that in spite of transient improvement observed in pa-
tients after treatment for H. pylori eradication, the dis-
comforts did not disappear completely, and exacerbation
episodes were mostly related to patient exposure to stress
events.
Analysis of esophageal motility changes detected by
manometry in our IBS patients produced a highly heter-
ogeneous picture of the impairments involved. Esopha-
geal motility changes were found in as many as 85% of
IBS patients. Analysis of the motility changes according
to study subgroups showed no significant differences be-
tween IBS patients with predominant diarrhea and those
with predominant constipation.
In contrast to some other related studies, we found
significantly lower values of the lower esophageal sphin-
cter pressure at rest and transient spontaneous sphin-
cter relaxations in IBS patients as compared with heal-
thy controls, and no difference between the two patient
subgroups18. Also, the abdominal segment of the sphin-
cter was shorter in IBS patients, with hiatal hernia veri-
fied in some of them. This finding is highly consistent
with the significant prevalence of reflux disease in IBS
patients.
Accordingly, IBS patients develop pathologic changes
of several motility parameters, the IBS subgroups differ-
ing according to some of them. Esophageal manometry
provides important diagnostic data that may influence
the treatment strategy. Development of electrogastro-
graphy, diagnostic procedure for assessment of func-
tional characteristics of stomach, will definitely help in
establishing gastric function impairement in patients
with IBS20. The results obtained in the present study
suggest that IBS may be associated with by far more ex-
tensive smooth muscle or innervation lesions than it
used to be believed before. However, a definite answer to
these questions requires additional studies.
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POREME]AJ FUNKCIJE JEDNJAKA U BOLESNIKA SA SINDROMOM IRITABILNOG CRIJEVA
S A @ E T A K
Cilj ove studije je bio odrediti prevalenciju znakova i simptoma povezanih s disfunkcijom jednjaka u bolesnika sa
sindromom iritabilnog crijeva (IBS), utvrditi poreme}aje senzorimotori~ke funkcije jednjaka na temelju manometrij-
skog ispitivanja te na taj na~in utvrditi korelaciju me|u njima. 30 bolesnika sa IBS, 14 s proljevom i 16 s konstipacijom
kao predominantnim simptomima je uklju~eno u studiju. Kontrolna grupa se je sastojala od 30 zdravih ispitanika.
Bolesnici su uklju~eni u studiju na temelju Rimskih kriterija za IBS. Nakon temeljito uzete povijesti bolesti i fizikalnog
statusa bolesnicima je u~injena ezofagogastroduodenoskopija i manometrija jednjaka. Vrijednosti manometrije jednja-
ka dobivene u zdravih ispitanika su slu`ile kao kontrolne vrijednosti za manometrijsko ispitivanje. Bolesnici s IBS su se
`alili na veliki broj kako koloni~kih tako i ekstrakoloni~kih simptoma i znakova, me|utim, nije bilo statisti~ki zna~ajne
razlike u prevalenciji ovih simptoma izme|u dvije podgrupe IBS bolesnika. U usporedbi sa zdravim ispitanicima bole-
snici s IBS imali su patolo{ki promjenjene vrijednosti ve}ine parametara motiliteta jednjaka. Komparacija dviju pod-
grupa bolesnika s IBS je pokazala razlike samo u pojedinim manometrijskim parametrima. Rezultati dobiveni u ovoj
studiji bi mogli objasniti za{to bolesnici s IBS ~esto imaju simptome povezane s gornjim dijelom gastrointestinalnog
trakta, kao {to su `garavica i bol u prsima nekardiogenog uzroka. Rezultati tako|er sugeriraju da bi IBS mogao biti
povezan sa zna~ajno pro{irenijim promjenama inervacije glatke muskulature nego {to se dosada mislilo.
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